NIL: Nilotinib
NIL is a Ligand Of Interest in 3GP0 designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
| 3GP0_NIL_A_1 | 91% | 12% | 0.061 | 0.952 | 1.56 | 2.41 | 7 | 14 | 0 | 0 | 100% | 1 |
| 5MO4_NIL_A_601 | 94% | 17% | 0.061 | 0.967 | 1.42 | 2.09 | 6 | 13 | 1 | 0 | 100% | 1 |
| 3CS9_NIL_A_600 | 90% | 36% | 0.073 | 0.961 | 0.96 | 1.42 | 2 | 9 | 0 | 0 | 100% | 1 |
| 9CJ1_NIL_A_402 | 69% | 10% | 0.097 | 0.913 | 2 | 2.22 | 10 | 18 | 0 | 0 | 100% | 1 |